Organon & Co. (OGN)
7.19
-0.10
(-1.37%)
USD |
NYSE |
Mar 02, 16:00
7.11
-0.08
(-1.11%)
Pre-Market: 06:19
Organon Research and Development Expense (Annual) : 366.00M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Merck & Co., Inc. | 12.51B |
| Amphastar Pharmaceuticals, Inc. | 71.24M |
| Plus Therapeutics, Inc. | 10.58M |
| Geron Corp. | 73.72M |
| Regeneron Pharmaceuticals, Inc. | 5.306B |